News

Cellarity has dosed the first subject in a Phase I study of oral medication, CLY-124, to treat sickle cell disease (SCD).
Even on stable days, people with SCD live with a range of complications: chronic anaemia, joint pain, slowed growth, ...
“We find that a lot of young people don’t pass the [fertility] test because you have to have an anti-mullerian hormone (AMH) level of about three and over nanograms per millilitre to be able to ...
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for ALYFTREK ® (deutivacaftor/tezacaftor/vanzacaftor) for the treatment of people with cystic ...
Most people with SCD seem to meet or exceed current level of physical activity recommendations for the general population, a ...
Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new ...
The World Health Organization has released its first-ever global guideline on the management of sickle cell disease during ...
A doctor says she’s scrambling to figure out how she’ll continue her work helping sickle cell disease patients after the ...
Pune: Jyoti has seen her first-born go through regular blood transfusions due to her sickle cell and thalassaemia conditions. So she was fearful and h.